搜尋結果
Novo Nordisk trims price for blockbuster obesity drug as competition heats up
Reuters· 4 日前, opens new tab raised its 2024 outlook on Thursday as the Danish drugmaker races to boost ...
GSK knew about Zantac cancer risk, attorneys tell jury in first trial
Reuters· 4 日前... discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical ...
Eli Lilly assures investors it can overcome the high-quality problem of too much demand
CNBC· 7 日前Eli Lilly 's raised guidance stole the show Tuesday, offsetting mixed first-quarter results and propelling shares higher ...